Bill

Bill > AB3330


CA AB3330

CA AB3330
Department of Consumer Affairs: boards: licensees: regulatory fees.


summary

Introduced
02/21/2020
In Committee
08/29/2020
Crossed Over
08/25/2020
Passed
08/31/2020
Dead
Signed/Enacted/Adopted
09/30/2020

Introduced Session

2019-2020 Regular Session

Bill Summary

An act to amend Sections 2499.5 and 4970 of, and to amend, repeal, and add Sections 208, 4971, 4984.7, 4989.68, 4996.3, and 4999.120 of, the Business and Professions Code, relating to the Department of Consumer Affairs.

AI Summary

This bill makes the following key provisions: 1. Increases the Controlled Substance Utilization Review and Evaluation System (CURES) fee from $6 to $11 beginning April 1, 2021, and then decreases it to $9 beginning April 1, 2023. This fee is assessed annually on licensed healthcare professionals authorized to prescribe, order, or dispense controlled substances to cover the costs of operating and maintaining the CURES prescription drug monitoring program. 2. Increases the biennial renewal fee for podiatric medical licenses from $1,100 to $1,318 on and after January 1, 2021. 3. Revises various fees for the Acupuncture Board, including decreasing the application and registration fee to supervise an acupuncture trainee, increasing the annual renewal fee for acupuncture trainees and supervisors, and adjusting other fees related to acupuncture practice. These changes are operative on January 1, 2021. 4. Revises the fee structure for various licensed mental health professions regulated by the Board of Behavioral Sciences, including marriage and family therapists, educational psychologists, clinical social workers, and professional clinical counselors. The new minimum and maximum fee amounts are set to take effect on January 1, 2021.

Committee Categories

Budget and Finance, Business and Industry

Sponsors (1)

Last Action

Chaptered by Secretary of State - Chapter 359, Statutes of 2020. (on 09/30/2020)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...